共查询到19条相似文献，搜索用时 500 毫秒
1.
张兵锋陶守松易文奇徐忠荣 《宜春学院学报》2017,(12):30-31
采用安全性高的溶剂如丙二醇和聚乙二醇以及研磨法这一制备方法,先制成前体脂质体,再水合形成脂质体,即得新型氯尼达明脂质体。制得的氯尼达明脂质体粒径约160 nm,并且较为均一;采用反透析法测得包封率为86.12%;体外释放结果显示具有一定的缓释性。本研究中制备氯尼达明脂质体的制备工艺相对简便,有利于工业生产,且包封率及稳定性较好,将能较好地提高氯尼达明的生物利用度。 相似文献
2.
以十八醇、聚乙二醇和乙基纤维素为包衣材料,采用干包衣法制备盐酸川芎嗪脉冲控释片,通过释放度试验考察处方及工艺因素对脉冲片体外释放的影响规律.可知崩解剂的用量和包衣材料中致孔剂的用量为影响药物体外释放的主要因素,可以根据需要调节药物的释放时滞,盐酸川芎嗪脉冲控释片在体外具有脉冲释放特性. 相似文献
3.
设计制备载有紫草素的纳米结构脂质载体,对其理化性质与体外释放进行测定及评价。正交试验设计法筛选出最优处方,制备紫草素纳米结构脂质载体。用透射电镜观察其形态,用激光纳米粒度仪测定粒径、Zeta电位。用葡聚糖凝胶G50柱分离,紫外分光光度法测定包封率。用动态透析法进行体外释放研究。制备的紫草素纳米结构脂质载体的粒径为(209.7±3.4)nm,Zeta电位为(-34.57±1.53)mV,包封率为(91.66±3.08)%。外观均一稳定,无沉淀,具有紫红色乳光,微观形态呈圆形小球,分散均匀,形状规整,获得了较理想的紫草素纳米结构脂质载体。 相似文献
4.
魔芋葡甘聚糖/聚乙烯吡咯烷酮水凝胶的制备及缓释性能研究 总被引：2，自引：0，他引：2
以魔芋葡甘聚糖（KGM）和聚乙烯吡咯烷酮（PVP）为原料,戊二醛（GA）为交联剂,合成了KGM／PVP半互穿网络水凝胶。通过红外光谱、X-衍射、SEM扫描电镜对水凝胶的结构进行了袁征,并且研究了KGM与PVP质量比、交联剂含量对水凝胶的溶胀度影响。在p14=2．2和pH=7．4条件下分别研究了交联度对溶胀动力学特性的影响,以及载药凝胶的体外释放行为。实验结果表明,KGM与PVP质量比对该凝胶的溶胀性能有一定的影响：KGM：PVP为1：1时,凝胶的溶胀度最大;随着交联剂含量的增加,凝胶的溶胀度、溶胀速率、药物的释放速率均逐渐降低;凝胶在pH=2．2时的溶胀度较高,溶胀速率、药物的释放速率均较快。 相似文献
5.
钩藤总碱凝胶骨架片的研制及释放度考察 总被引：2，自引：0，他引：2
董艳辉 《通化师范学院学报》2003,24(6):35-38
以羟丙甲基纤维素(HPMC)为骨架材料，采用湿法制粒，制备钩藤总碱缓释片。以体外释放度实验研究了缓释片的释药机理及其影响因素。结果表明：钩藤总碱凝胶骨架片的释放符合Higuchi方程，其释放速度受多种因素的影响，如HPMC、乳糖、微晶纤维素的用量，附加剂的调节和控制。 相似文献
6.
7.
Peng-yan QIAO Fang-fang LI Li-min DONG Tao XU Qiu-fei XIE 《Journal of Zhejiang University. Science. B》2014,15(4):382-392
研究目的：本研究应用海藻酸钠-壳聚糖微囊保护成骨细胞,接种到β-磷酸三钙/磷酸钙骨水泥（β-TCP/CPC）浆料中,使β-TCP/CPC骨修复材料具有一定的细胞活性,同时提高固化后材料的孔隙率和孔径,以最终实现提高β-TCP/CPC骨水泥的降解速度,加快成骨和骨修复。创新要点：本研究首次应用海藻酸钠-壳聚糖微胶囊包封成骨细胞与CPC浆料复合,复合后实现自动细胞释放,释放出的细胞具有良好的生物学活性。研究方法：（1）高压静电成囊法制备载小鼠成骨前体细胞（MC3T3-E1）的海藻酸钙和海藻酸钠-壳聚糖微胶囊;（2）微囊化MC3T3-E1细胞,进行体外培养,使用细胞计数试剂盒（CCK-8）检测细胞活性,并用钙黄绿素-AM（Calcein-AM）和碘化丙啶（PI）进行活死细胞双重染色;（3）微囊化MC3T3-E1细胞与β-TCP/CPC浆料复合培养后,激光共聚焦扫描显微镜和环境扫描电子显微镜观测细胞在材料上的释放、粘附,CCK-8法检测材料上细胞的活力,碱性磷酸酶（ALP）检测观察细胞的分化状况,茜素红染色观察释放细胞的矿化能力。重要结论：海藻酸钠-壳聚糖微胶囊可作为可注射磷酸钙骨水泥内部接种成骨细胞并实现细胞释放的良好载体,释放出的成骨细胞具有良好的生物学活性。 相似文献
8.
王德堂 《荆门职业技术学院学报》2015,(2)
目的：制备复方奥硝唑茶多酚口腔温敏型凝胶并对其体外释药进行考察。方法：以奥硝唑和茶多酚为主药,以泊洛沙姆P407、泊洛沙姆P188及聚乙二醇400的用量为考察因素,胶凝温度为考察指标进行正交试验筛选处方,以磷酸盐缓冲液为释放介质,按桨法测定主药的体外释放度。结果：最佳处方为泊洛沙姆P407为16％,泊洛沙姆P188为2％,聚乙二醇400为12％,胶凝温度为36．4℃,药物的释放时间可达4 d以上。结论：该处方设计合理,制备工艺简单,质量可靠,所得复方奥硝唑茶多酚口腔温敏型凝胶缓释性能良好。 相似文献
9.
采用乳化-交联法研究了左氧氟沙星磁性明胶微球的制备及其缓释性能.选取左氧氟沙星与明胶的比例、水油比、明胶浓度、戊二醛用量四个因素进行正交实验,优化最佳合成工艺.采用动态透析法测定载药微球的体外释放特性,同时对载药微球的形态、粒径、磁性及包覆情况进行表征.结果表明,载药微球最佳制备工艺为:明胶浓度15%,左氧氟沙星明胶比1∶2,水油比1∶5,戊二醛用量3.6mL;包封率为8.89%,载药量为51.36%;微球5h体外累积释药百分率人工肠液中达到64%,人工胃液中达到72%,具有较好的缓释性能,体外释放符合一级动力学方程;磁性明胶微球成球性良好,分布均匀,Fe3O4及左氧氟沙星被明胶包覆. 相似文献
10.
冷冻干燥法制备隐丹参酮纳米脂质体 总被引：1，自引：0，他引：1
张晓伟 《忻州师范学院学报》2008,24(5)
目的：用大豆卵磷脂作为载体,以隐丹参酮作为模型药。制备隐丹参酮纳米脂质体。方法：用超声一匀浆一冷冻干燥法制备隐丹参酮纳米脂质体。采用透射电镜测试隐丹参酮脂质体的粒径,用激光粒度分布仪测试平均粒径及粒度分布。结果：冷冻干燥法制备隐丹参酮纳米脂质体的粒径20—80nm之间。随着大豆卵磷脂与隐丹参酮配比的减小,粒径逐渐减小,包封率逐渐减小。体外释药表现为零级动力学释药特征。结论：用超声一匀浆一冷冻干燥法制备隐丹参酮纳米脂质体的方法可行。 相似文献
11.
12.
Hong Zhang Rui-ying Li Xia Lu Zhen-zhen Mou Gui-mei Lin 《Journal of Zhejiang University. Science. B》2012,13(12):981-989
Docetaxel (DTX), as a member of taxoid family, has been widely used in the treatment of cancers. The present study prepared pH-sensitive DTX-loaded liposomes (DTX-Lips) by thin-film dispersion method and various physico-chemical and morphological properties were examined. The pH sensitivity of in vitro DTX release and the in vivo pharmacokinetics and tissue distribution using Kunming mice were also investigated. The mean particle size and zeta potential of DTX liposomes were (277±2) nm and (−32.60±0.26) mV, respectively. Additionally, in vitro drug release study showed that the cumulative release rate was 1.3 times more at pH 5.0 than at pH 7.4, suggesting a pH-dependent release ability of DTX-Lips. Pharmacokinetic and pharmaceutical studies in comparison with Duopafei® showed that the half-time period (t
1/2) and area under the curve (AUC) of DTX-Lips in mouse plasma were 1.8 times longer and 2.6 times higher, respectively, and that DTX-Lips selectively accumulated in macrophage-rich organs such as liver and spleen. These results together suggest that the DTX-Lips could be a promising formulation for the clinical administration of DTX. 相似文献
13.
用聚乙二醇(PEG)包覆脂质体来提高脂质体的稳定性．先用反相蒸发法制备醋酸泼尼松龙脂质体,然后将PEG溶液与醋酸泼尼松龙脂质体混合即可制得PEG包覆的脂质体,原子力扫描探针显微镜照片与粒径证明PEG在脂质体外形成了一层膜,相比较于未包覆的脂质体,PEG包覆的脂质体的包封率和粒径都有所增加,泄漏率降低,其泄漏率随时间和温度的增加而增加,但低于未包覆的脂质体．通过测定粒径和泄漏率的变化说明包覆PEG的脂质体要比未包覆的稳定． 相似文献
14.
《天津大学学报(英文版)》2015,(5)
The aim of this work was to develop an alginate-casein composite microsphere as a bioactive vehicle for oral administration of nutrients by a simple extrusion dripping method. Riboflavin was selected as a model drug, and the microencapsulation efficiency was raised to 97.94% after optimizing the preparation conditions by response surface methodology. In vitro release studies showed that riboflavin was released completely from alginate-casein microspheres in simulated intestinal fluids. Meanwhile, the morphology, structure and interaction between alginate and casein were characterized by scanning electron microscopy(SEM) and Fourier transform infrared(FTIR) spectra. 相似文献
15.
乌索酸固体分散体的制备及其体外溶出度研究 总被引：1，自引：0，他引：1
目的：提高制剂中乌索酸的溶出度.方法：选择聚乙烯吡咯烷酮K30、泊洛沙姆188两种载体,用溶剂法制备乌索酸固体分散体;建立高效液相色谱-光电二极管阵列检测器法测定固体分散体的体外溶出度,并检测分析了乌索酸的峰纯度.结果：高效液相色谱法测定乌索酸的溶出度,结果准确可靠、稳定、无载体的干扰.制备的固体分散体能显著地提高乌索酸的体外溶出度;以聚乙烯吡咯烷酮为载体制备的固体分散体溶出速度快于泊洛沙姆.结论：选择聚乙烯吡咯烷酮为载体制备乌索酸固体分散体可显著提高乌索酸的体外溶出度. 相似文献
16.
该文设计了以聚乳酸(polylactic acid,PLA)为基材,阿司匹林为模型药物,磁性粒子(Fe3O4)响应的静电纺丝法制备具有磁响应性的药物缓释纳米纤维镇痛贴,避免了所载药物在临床应用中存在的不良反应及其他不足。同时,对样品的纤维形貌、体外缓释、控释等性能进行测试。结果表明,利用静电纺丝方法制备的阿司匹林镇痛帖具有较好的药物包封率,在体外的缓释时间能够达到72 h以上,同时给予外加磁场时,能够加速药物的释放,具有磁响应性能。该实验项目结合了药学、材料科学、化学与机械工程等诸多学科,具有综合性和可操作性,作为制药工程专业本科生实践教学综合性实验项目,可培养学生的综合技能和创新能力。 相似文献
17.
目的：确立白藜芦醇脂质体比白藜芦醇是否具有更好的肝靶向性。方法：采用薄膜超声分散法制备白藜芦醇脂质体,从小鼠尾静脉注射白藜芦醇和白藜芦醇脂质体,以紫外检测法检测小鼠肝脏中白藜芦醇含量为考察指标。比较白藜芦醇与白藜芦醇脂质体在0．5h、2h、8h后在肝脏中的存留量确定肝靶向性差异。结果：白藜芦醇脂质体在尾静脉注射0．5h、2h、8h后在肝脏比单纯白藜芦醇具有更高的肝组织分布量。结论：白藜芦醇脂质体具有更好的肝靶向性。 相似文献
18.
OBJECTIVE: The purpose of this study was to describe the demographic, substance use, and treatment variables of alcohol and other drug (AOD) treatment seeking pregnant women. This study also compared women on these variables based on Child Protective Service (CPS) status. METHOD: Secondary data of all pregnant women with at least one child entering all publicly funded AOD treatment programs (N=678), in a southwest county, over a 3-year period were analyzed to examine the differences between pregnant women also involved with CPS and those not involved with CPS. RESULTS: Pregnant women reporting CPS involvement were similar to non-CPS women on demographic variables but differed on drug use and treatment variables. CPS women were more likely to report marijuana use as their primary problem drug, be mandated to treatment, attend day treatment and be released from treatment unsatisfactorily compared to the non-CPS pregnant women. Those without CPS involvement were more likely to report cocaine or crack as their primary drug, attend outpatient treatment and be found to have a satisfactory release from treatment compared to those with CPS involvement. Results from the multiple logistic regression analysis found that the significant predictors of CPS involvement were mandated status and unsatisfactory treatment release. CONCLUSIONS: Differences in treatment outcomes may be based on AOD agencies' difficulty in working with mandated clients and/or with the multiple demands placed by CPS on clients as part of their treatment plans. Further research is needed to determine reasons for CPS clients' high failure rates in AOD treatment. 相似文献
19.
与陆生放线菌相比,海洋放线菌已经进化出了独特的代谢途径,它们的次级代谢产物显示出化学结构多样性、复杂性以及更强的生物活性,这些活性物质为新药研究、开发,特别是抗肿瘤药物开发提供丰富的先导化合物。本文对海洋放线菌抗肿瘤活性物质的研究进展进行了概述。 相似文献